Brad Jongeling

Brad Jongeling serves as a Clinical Senior Lecturer within the Department of Paediatrics at the UWA Medical School, The University of Western Australia. His academic and clinical work centers on child and adolescent mental health, with a strong emphasis on neurodevelopmental disorders including Attention Deficit Hyperactivity Disorder (ADHD) and Pervasive Developmental Disorders.

His research portfolio demonstrates expertise in several key areas: ADHD and its functional impairments, mental health in children, neurodevelopmental disorders, and infant development. He has published on topics ranging from the impact of maternal technology use on infant development to clinical case studies of fetal alcohol spectrum disorder and neurodevelopmental concerns in preterm infants. His work often addresses comorbidities and functional outcomes in pediatric populations.

Analysis of his recent publications (2020-2024) reveals a consistent focus on clinical pediatric research, particularly longitudinal studies of ADHD progression and its long-term effects, investigations into healthcare access through Western Australian private pediatric waiting list surveys, and neurodevelopmental assessments in vulnerable infant populations. His research bridges clinical practice, public health, and policy implications for child health services.

Dr. Jongeling participated as an investigator in the NHMRC-funded project "Body Composition PEA POD" (2014), which examined infant body composition. This project received significant attention from multiple news outlets and academic platforms, including coverage by 8 news outlets, 15 X users, and 96 Mendeley readers, reflecting its impact on pediatric research.

His contributions align with UN Sustainable Development Goals related to good health and well-being, particularly through research aimed at improving child health outcomes and addressing developmental disorders in clinical and community settings.